检索结果-南通市图书馆

international recommendations on Calculation of Absorbed Dose in Biota:A Comprehensive Revue

Journal of Environmental Protection 2014年第9期5卷 751-759页

作者： Wagner de S.Pereira Alphonse Kelecom Multidisciplinary Group of Radio Protection(GMR) Servico de RadioprotecaoUnidade de Tratamento de MinerioIndustrias Nucleares do BrasilCaldasBrazil Laboratory of Radiobiology and Radiometry Pedro Lopes dos Santos(LARARA-PLS) Group of Environmental Themes Assessment(GETA)Universidade Federal Fluminense(UFF)NiteroiBrazil

Since the early times, radioprotection has been focused on the human being. Currently this approach has changed, being now also necessary to take care of the protection of the environment from unwanted effects of ionizing radiation. To this end, several institutions (UNSCEAR, ICRP, IAEA, DOE, ACRP) and consortia of institutions (FASSET, ERICA) have established procedures in order to protect the biota of such effects. Developed procedures are based on the calculation of the absorbed dose in biota (ICRP, DOE, IAEA), or on environmental risk assessment―ERA (DOE, ACRP, FASSET, ERICA);but even in this latter approach the parameters used are related to the absorbed doses in biota. The calculation of dose is the standard procedure in human radioprotection, and this points such an approach as the most interesting for providing a convergence between human and nonhuman (= biota) radioprotections. On the other hand, the ERA approach is easier to apply, because this methodology is used in several countries for non-radioactive contamination assessments. Since the world radioprotection system follows a number of institutions (UNSCEAR, ICRP, IAEA and regulatory institutions of member countries) that use dose calculation, this appears to be the way for biota radioprotection. We here review and comment the evolution of the concepts and approaches of the recommendations for radioprotection of non-human biota.

关键词： Biota Absorbed Dose Radioprotection international recommendations

来源：

维普期刊数据库评论

在线全文

维普期刊数据库

学校读者我要写书评

暂无评论

Magnesium sulfate and fetal neuroprotection: overview of clinical evidence

引用

Neural Regeneration Research 2018年第12期13卷 2044-2049页

作者： Clément Chollat Stéphane Marret Institut National de la Santé et de la Recherche Médicale U1245 Genetics and Pathophysiology of Neurodevelopmental Disorders Team 4Neovasc Institute of Research and Innovation in Biomedicine Rouen School of Medicine Normandy University Department of Neonatal Intensive Care Port Royal University Hospital Department of Neonatal Pediatrics and Intensive Care and Neuropediatrics Charles-Nicolle University Hospital

Antenatal administration of magnesium sulfate is an important part of the neuroprotective strategy for preterm infants. Strong evidence from five randomized controlled trials and five meta-analyses has demonstrated that magnesium sulfate, when administered before preterm delivery, significantly reduces the risk of cerebral palsy at two years. Through secondary analyses of randomized controlled trials and other original clinical studies, this state-of-the-art review highlights the absence of serious adverse effects in both pregnant women and neonates, as well as the impact of maternal body mass index and preeclamptic status on the maternal and neonatal magnesium levels, which could influence the magnitude of the neuroprotective effect. Although antenatal magnesium sulfate is a cost-effective strategy, some practice surveys have demonstrated that the use of magnesium sulfate is not sufficient and that its use is heterogeneous, differing among different maternity wards. Since 2010, an increasing number of obstetrical societies have recommended its use to improve the neurological outcomes of preterm infants, especially the international Federation of Gynecology and Obstetrics and World Health Organization in 2015, and France in 2017. Considering the neuroprotective impact of magnesium sulfate when administered before delivery, postnatal administration should be considered, and its effects should be assessed using randomized controlled trials.

关键词： magnesium sulfate preterm birth neuroprotection cerebral palsy neurodevelopment international recommendations clinical studies meta-analysis preeclampsia cost-effectiveness

来源：

维普期刊数据库

同方期刊数据库评论

在线全文

学校读者我要写书评

暂无评论

欢迎您,

建议与咨询留下您的常用邮箱和电话号码，以便我们向您反馈解决方案和替代方法

时间限定

文献类型

馆藏选择

核心期刊

语言

文献类型

帮助

文字说明：

检索规则说明：

检索范例：

分类表

所选分类

限定检索结果

文献类型

馆藏范围

日期分布

学科分类号

主题

机构

作者

语言

在线全文

在线全文

请选择保存的检索档案：

请选择收藏分类：

通借通还

欢迎您,

建议与咨询 留下您的常用邮箱和电话号码，以便我们向您反馈解决方案和替代方法

时间限定

文献类型

馆藏选择

核心期刊

语言

文献类型

帮助

文字说明：

检索规则说明：

检索范例：

分类表

所选分类

限定检索结果

文献类型

馆藏范围

日期分布

学科分类号

主题

机构

作者

语言

在线全文

在线全文

请选择保存的检索档案： 新增检索档案 确定 取消

请选择收藏分类： 新增自定义分类 确定 取消

通借通还

建议与咨询留下您的常用邮箱和电话号码，以便我们向您反馈解决方案和替代方法

请选择保存的检索档案：

请选择收藏分类：